PMDA drug package insert
ウブレチド点眼液1%
PMDA Prescription drug · 鳥居薬品株式会社 · package insert Jul 25, 2023
Key facts
| Brand names | ウブレチド点眼液1% |
|---|---|
| Nonproprietary names | ジスチグミン臭化物 |
| Companies | 製造販売元／鳥居薬品株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 緑内障、調節性内斜視 重症筋無力症（眼筋型）治療剤 |
| Therapeutic category codes | 871312 |
| YJ codes | 1312704Q2020 |
| Approval numbers | 14700AMZ00807000 |
| Package insert edition | 第1版 |
| Package insert date | Jul 25, 2023 |
| PMDA document key | 480306_1312704Q2020_1 |
| PMDA company code | 480306 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: